UroGen Pharma Ltd (URGN)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -9.146 | -40.565 | -84.482 | -68.735 | -79.215 | -91.681 | -85.981 | -65.138 |
Return on Equity (%) | -11.912 | -47.158 | -95.401 | -77.772 | -92.883 | -211.553 | 271.243 | 132.292 |
Return on Invested Capital (%) | 4.939 | -47.39 | -97.874 | -99.081 | -115.434 | -186.321 | -1409.228 | -431.603 |
Operating Margin (%) | 4.552 | -244.545 | -6696.099 | -584144.444 | -1057.318 | -227.339 | -154.746 | -101.083 |
Net Profit Margin (%) | -11.072 | -245.158 | -6707.181 | -584144.444 | -1088.94 | -230.673 | -170.584 | -123.613 |
Book Value Per Share | 2.175 | 3.617 | 4.208 | 6.877 | 3.522 | 0.304 | -3.155 | -1.808 |
Earnings Per Share | -0.259 | -1.056 | -3.534 | -4.01 | -4.696 | -4.007 | -3.876 | -2.835 |
Cash Per Share | 2.849 | 1.953 | 4.733 | 1.895 | 1.932 | 1.604 | 1.956 | 2.635 |
Working Capital Per Share | 2.521 | 3.56 | 4.147 | 4.926 | 3.442 | 3.327 | 3.707 | 3.826 |
Operating Profit Per Share | 2.334 | 0.399 | -0.032 | 0.001 | 0.394 | 1.551 | 2.002 | 2.034 |
EBIT Per Share | -0.259 | -1.055 | -3.528 | -4.01 | -4.573 | -3.955 | -3.814 | -2.727 |
EBITDA Per Share | -0.259 | -1.055 | -3.528 | -4.01 | -4.573 | -3.955 | -3.814 | -2.727 |
Free Cash Flow Per Share | -0.195 | -1.052 | -3.527 | -4.009 | -4.667 | -4.01 | -3.9 | -2.852 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 7.026 | 10.586 | 7.593 | 7.629 | 5.394 | 5.111 | 5.39 | 5.421 |
Quick Ratio | 6.866 | 10.405 | 7.543 | 7.576 | 5.145 | 4.561 | 4.745 | 4.909 |
Inventory Turnover (Days) | 2.186 | 14.138 | N/A | N/A | 60.756 | 36.711 | 24.529 | 25.034 |
Shares Outstanding | 2.31M | 13.75M | 16.22M | 21.03M | 22.17M | 22.46M | 23.13M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 22.73M | 23.01M | 23.13M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -124.564 | N/A | N/A | N/A | -158.591 |
Net Profit Margin (%) | N/A | N/A | N/A | -175.739 | N/A | N/A | N/A | -171.908 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 3.803 | N/A | N/A | N/A | 7.47 |
Quick Ratio | N/A | N/A | N/A | 3.105 | N/A | N/A | N/A | 6.797 |
Inventory Turnover (Days) | N/A | N/A | N/A | 116.048 | N/A | N/A | N/A | 140.764 |
Market Cap | 585.31M |
Price to Earnings Ratio | -5.99 |
Price to Sales Ratio | 7.4 |
Price to Cash Ratio | 6.44 |
Price to Book Ratio | -9.39 |
Dividend Yield | - |
Shares Outstanding | 36.13M |
Average Volume (1 week) | 442.28k |
Average Volume (1 Month) | 539.05k |
52 Week Change | 75.73% |
52 Week High | 24.13 |
52 Week Low | 8.69 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.